Related Experiment Video

Updated: Jul 5, 2026

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

Potential therapeutic role of statins in neurological disorders

Maurizio Bifulco1, Anna Maria Malfitano, Giuseppe Marasco

  • 1Dipartimento di Scienze Farmaceutiche, University di Salerno, Via Ponte Don Melillo 84084 Fisciano, Salerno, Italy. maubiful@unisa.it

Expert Review of Neurotherapeutics
|May 7, 2008
PubMed

Insights

Statins, HMG-CoA reductase inhibitors, offer cardiovascular benefits and show promise for neurological disorders like Alzheimer's and Parkinson's disease. Further research is needed to confirm their efficacy and safety in treating these conditions.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Statins are widely prescribed for cardiovascular disease prevention by inhibiting HMG-CoA reductase.
  • Established effects include cholesterol reduction and coronary heart disease prevention.
  • Emerging evidence suggests pleiotropic effects beyond lipid-lowering.

Purpose of the Study:

  • To review the protective effects of statins on various neurological diseases.
  • To explore potential therapeutic implications of statins in neurodegenerative and other neurological conditions.
  • To summarize current data on statin use in neurological disorders.

Main Methods:

  • Literature review of existing studies on statins and neurological diseases.
  • Analysis of evidence for statins' mechanisms of action in the central nervous system.
  • Synthesis of data regarding clinical outcomes and safety profiles.

Main Results:

  • Statins exhibit endothelial protection via the nitric oxide synthetase system.
  • Antioxidant, anti-inflammatory, and antiplatelet effects contribute to neuroprotection.
  • Potential therapeutic benefits observed in stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and brain tumors.

Conclusions:

  • Statins demonstrate promising protective effects across a range of neurological disorders.
  • Current data suggest statins are safe and potentially effective for these conditions.
  • Further clinical trials and research are necessary to validate these findings and optimize treatment strategies.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...